Dr. Marco Tatangelo, M.D

NPI: 1477992147
Total Payments
$836.88
2024 Payments
$461.02
Companies
11
Transactions
45

Payment Breakdown by Category

Food & Beverage$774.71 (92.6%)
Other$57.00 (6.8%)
Education$5.17 (0.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $774.71 43 92.6%
Debt forgiveness $57.00 1 6.8%
Education $5.17 1 0.6%

Top Paying Companies

Company Total Records Latest Year
Supernus Pharmaceuticals, Inc. $463.14 28 $0 (2024)
Merck Sharp & Dohme LLC $76.90 3 $0 (2024)
Welch Allyn $57.00 1 $0 (2021)
PFIZER INC. $52.70 3 $0 (2024)
Novo Nordisk Inc $38.50 2 $0 (2024)
Neurocrine Biosciences, Inc. $38.17 2 $0 (2023)
Lilly USA, LLC $33.71 2 $0 (2024)
AbbVie Inc. $28.61 1 $0 (2023)
Otsuka America Pharmaceutical, Inc. $22.13 1 $0 (2020)
Organon Llc $13.73 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $461.02 25 Supernus Pharmaceuticals, Inc. ($299.09)
2023 $194.44 11 Supernus Pharmaceuticals, Inc. ($127.66)
2022 $50.93 3 Supernus Pharmaceuticals, Inc. ($36.39)
2021 $69.25 2 Welch Allyn ($57.00)
2020 $36.49 2 Otsuka America Pharmaceutical, Inc. ($22.13)
2018 $12.46 1 PFIZER INC. ($12.46)
2017 $12.29 1 GlaxoSmithKline, LLC. ($12.29)

All Payment Transactions

45 individual payment records from CMS Open Payments — Page 2 of 2

Date Company Product Nature Form Amount Type
12/05/2023 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $23.45 General
Category: PSYCHOLOGY
11/20/2023 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $16.69 General
Category: PSYCHOLOGY
11/08/2023 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $20.99 General
Category: PSYCHOLOGY
10/24/2023 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $24.50 General
Category: PSYCHOLOGY
10/18/2023 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $15.09 General
Category: PSYCHOLOGY
10/11/2023 AbbVie Inc. Food and Beverage In-kind items and services $28.61 General
10/05/2023 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $16.48 General
Category: PSYCHOLOGY
09/14/2023 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $17.25 General
Category: Neuropsychiatry
08/10/2023 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $5.29 General
Category: PSYCHOLOGY
07/12/2023 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Education In-kind items and services $5.17 General
Category: PSYCHOLOGY
02/09/2023 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $20.92 General
Category: Neuropsychiatry
12/20/2022 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $21.00 General
Category: PSYCHOLOGY
09/08/2022 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $15.39 General
Category: PSYCHOLOGY
05/12/2022 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $14.54 General
Category: Diabetes
11/23/2021 Welch Allyn None (Device) Debt forgiveness Cash or cash equivalent $57.00 General
Category: Not Applicable
10/13/2021 Lilly USA, LLC TRULICITY (Drug), JARDIANCE Food and Beverage In-kind items and services $12.25 General
Category: Diabetes
10/08/2020 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $22.13 General
Category: PSYCHIATRY
01/13/2020 PFIZER INC. PREVNAR 13 (Biological) Food and Beverage In-kind items and services $14.36 General
Category: VACCINES
09/18/2018 PFIZER INC. PREVNAR - 13 (Biological), TRUMENBA Food and Beverage In-kind items and services $12.46 General
Category: VACCINES
03/30/2017 GlaxoSmithKline, LLC. Food and Beverage In-kind items and services $12.29 General

About Dr. Marco Tatangelo, M.D

Dr. Marco Tatangelo, M.D is a Pediatrics healthcare provider based in Muskegon, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2013. The National Provider Identifier (NPI) number assigned to this provider is 1477992147.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marco Tatangelo, M.D has received a total of $836.88 in payments from pharmaceutical and medical device companies, with $461.02 received in 2024. These payments were reported across 45 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($774.71).

Practice Information

  • Specialty Pediatrics
  • Location Muskegon, MI
  • Active Since 06/17/2013
  • Last Updated 01/02/2022
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1477992147

Products in Payments

  • Qelbree (Drug) $299.09
  • QELBREE (Drug) $164.05
  • GARDASIL (Biological) $76.90
  • None (Device) $57.00
  • INGREZZA (Drug) $38.17
  • PREVNAR 20 (Biological) $25.88
  • Rybelsus (Drug) $23.96
  • REXULTI (Drug) $22.13
  • MOUNJARO (Drug) $21.46
  • Ozempic (Drug) $14.54
  • PREVNAR 13 (Biological) $14.36
  • NEXPLANON (Drug) $13.73
  • PREVNAR - 13 (Biological) $12.46
  • TRULICITY (Drug) $12.25

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Muskegon